"中医药健康养生文化创造性转化、创新性发展'' 学术研讨会召开

2017-09-22 佚名 中国中医

9月15日,由国家中医药管理局“中医药健康养生文化创造性转化、创新性发展研究”课题组、上海中医药大学中医药文化研究与传播中心和《中医药文化》编辑部共同主办的“中医药健康养生文化创造性转化、创新性发展”学术研讨会在上海中医药大学召开。国家中医药管理局办公室主任查德忠,该课题组组长、安徽中医药大学原校长、上海中医药大学科技人文研究院院长王键教授,上海中医药大学季光副校长以及来自全国10余所高等中医药院

9月15日,由国家中医药管理局“中医药健康养生文化创造性转化、创新性发展研究”课题组、上海中医药大学中医药文化研究与传播中心和《中医药文化》编辑部共同主办的“中医药健康养生文化创造性转化、创新性发展”学术研讨会在上海中医药大学召开。国家中医药管理局办公室主任查德忠,该课题组组长、安徽中医药大学原校长、上海中医药大学科技人文研究院院长王键教授,上海中医药大学季光副校长以及来自全国10余所高等中医药院校、科研单位、企业及医疗机构的代表50余人参加会议

查德忠强调了该课题的重要性和时代意义,并指出,研讨会聚焦中医药健康养生文化创造性转化、创新性发展这个主题,从多个角度介绍经验、碰撞交流,激发出新的思路。在激励课题组进一步研究、吸纳和消化研讨会成果的基础上,他提出三点建议。第一,把握课题的定位、任务和目标,坚定不移、不忘初心;第二,在理论研究的基础上,为主管部门建言献策,提出政策建议,使研究成果能够真正落地,付诸实施,产生效果;第三,进一步邀请更多其他领域专家共同参与研究探讨,拓展思路。

王键代表课题组介绍了课题背景及总体开展情况。该课题从中医药健康养生文化的历史脉络、理论框架、实践体系和传播模式四个方面展开研究,并成立了由孙光荣、王琦、陈涤平、温长路、靳琦、孙晓生、何清湖、马烈光、王旭东、梁尚华教授等组成的核心专家组。他表示,中医药文化尤其是养生文化在文化传承和发展中具有重要作用和独特价值。中医药健康养生文化的研究需要定位准确、理论框架范围适度、脉络清晰。在实践体系方面要力求具体化、实用化、产业化和科学化;在文化传播方面,要力求大众化、通俗化、现代化。以服务求支持,以贡献求发展,使得“两创”工作能够更好地指导现实,面向未来。

王键对下一步研究工作提出五点思考:第一,中医药健康养生文化创造性转化、创新性发展,既是一个研究课题,又是一个系统工程,更是一种人文的实践。第二,养生无处不在、无时不在,而养生文化的传播和渠道,同样如此,从历史脉络到理论框架、从实践体系到传播模式,有许多问题需要回答,有许多工作需要探索。第三,关于中医药健康养生文化的“两创”研究,要落实研究工作的落地要求,突出可实施和操作的研究成果,有效指导和服务于养生实践,真正达到内化中华优秀传统文化价值于心,外化中医健康养生实践于行;做到目标明确、思路清晰、定位合理、方法科学、路径明晰、重点突出、整体呼应。体现时代性、把握规律性、富于创造性、重在实效性。第四,中医药健康养生文化的两创研究,必须在传统的基础之上,在继承的过程中有所创造、有所创新。课题组要着力把握研究定位、不忘初心;立足传统、服务当下、引领时尚;立足行业,惠及民众,促进健康;立足国内、面向海外、主导全球。第五,希望将会议成果学以致用,落到实处,避免空化、泛化、虚化和玄化,按时高质量地完成研究报告,形成高水平的指导意见和富有价值的政策建议;希望课题组的研究工作进一步凝聚更多行业内外的专家,把中医药健康养生文化的“两创”研究,形成一个稳定的研究方向,组建一支团队,构筑一个研究平台,打造一个学科体系,不断推出一批研究成果。

季光在欢迎致辞中回顾了近年来上海中医药大学在中医药文化研究与传播方面所做的努力,并提出了学校“以社会主义核心价值观为引领,弘扬优秀的中医药传统文化;推进中医药文化的传承和人文素质教育工程;加强中医药文化的国际传播”的具体任务。

会上,广州中医药大学孙晓生教授回顾了中医药文化进校园十年百场实践,辽宁中医药大学朱爱松教授讲述了中国传统文化元素在中医药健康养生实践中的传承与发展,北京中医药大学谭巍教授分享了健康养生文化社交媒体传播模式研究等等。专家们从中医药健康养生文化的历史脉络、理论框架、文献研究、国际传播、产业创新、教育实践等诸多层面、不同角度进行了深入阐述和热烈探讨。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1994771, encodeId=f4351994e7146, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Jul 07 02:22:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285424, encodeId=d344128542422, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409074, encodeId=f99c14090e439, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554925, encodeId=3e46155492500, content=<a href='/topic/show?id=98272e757e2' target=_blank style='color:#2F92EE;'>#健康养生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27757, encryptionId=98272e757e2, topicName=健康养生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411314562615, createdName=stfoxst, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=246693, encodeId=bdb7246693b6, content=发扬国粹, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/17/d5be787205d0c34875ae55a61f49c17d.jpg, createdBy=2a762072202, createdName=路人甲115, createdTime=Fri Sep 22 20:51:27 CST 2017, time=2017-09-22, status=1, ipAttribution=)]
    2018-07-07 kcb069
  2. [GetPortalCommentsPageByObjectIdResponse(id=1994771, encodeId=f4351994e7146, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Jul 07 02:22:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285424, encodeId=d344128542422, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409074, encodeId=f99c14090e439, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554925, encodeId=3e46155492500, content=<a href='/topic/show?id=98272e757e2' target=_blank style='color:#2F92EE;'>#健康养生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27757, encryptionId=98272e757e2, topicName=健康养生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411314562615, createdName=stfoxst, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=246693, encodeId=bdb7246693b6, content=发扬国粹, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/17/d5be787205d0c34875ae55a61f49c17d.jpg, createdBy=2a762072202, createdName=路人甲115, createdTime=Fri Sep 22 20:51:27 CST 2017, time=2017-09-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1994771, encodeId=f4351994e7146, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Jul 07 02:22:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285424, encodeId=d344128542422, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409074, encodeId=f99c14090e439, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554925, encodeId=3e46155492500, content=<a href='/topic/show?id=98272e757e2' target=_blank style='color:#2F92EE;'>#健康养生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27757, encryptionId=98272e757e2, topicName=健康养生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411314562615, createdName=stfoxst, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=246693, encodeId=bdb7246693b6, content=发扬国粹, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/17/d5be787205d0c34875ae55a61f49c17d.jpg, createdBy=2a762072202, createdName=路人甲115, createdTime=Fri Sep 22 20:51:27 CST 2017, time=2017-09-22, status=1, ipAttribution=)]
    2017-09-24 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1994771, encodeId=f4351994e7146, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Jul 07 02:22:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285424, encodeId=d344128542422, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409074, encodeId=f99c14090e439, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554925, encodeId=3e46155492500, content=<a href='/topic/show?id=98272e757e2' target=_blank style='color:#2F92EE;'>#健康养生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27757, encryptionId=98272e757e2, topicName=健康养生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411314562615, createdName=stfoxst, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=246693, encodeId=bdb7246693b6, content=发扬国粹, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/17/d5be787205d0c34875ae55a61f49c17d.jpg, createdBy=2a762072202, createdName=路人甲115, createdTime=Fri Sep 22 20:51:27 CST 2017, time=2017-09-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1994771, encodeId=f4351994e7146, content=<a href='/topic/show?id=3d51e345936' target=_blank style='color:#2F92EE;'>#研讨会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=14, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73459, encryptionId=3d51e345936, topicName=研讨会)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87b1109, createdName=kcb069, createdTime=Sat Jul 07 02:22:00 CST 2018, time=2018-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285424, encodeId=d344128542422, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409074, encodeId=f99c14090e439, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1554925, encodeId=3e46155492500, content=<a href='/topic/show?id=98272e757e2' target=_blank style='color:#2F92EE;'>#健康养生#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27757, encryptionId=98272e757e2, topicName=健康养生)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=411314562615, createdName=stfoxst, createdTime=Sun Sep 24 08:22:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=246693, encodeId=bdb7246693b6, content=发扬国粹, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/17/d5be787205d0c34875ae55a61f49c17d.jpg, createdBy=2a762072202, createdName=路人甲115, createdTime=Fri Sep 22 20:51:27 CST 2017, time=2017-09-22, status=1, ipAttribution=)]
    2017-09-22 路人甲115

    发扬国粹

    0